News Posts List
UCB files BRIVIACT® (brivaracetam) CV in the U.S. as monotherapy treatment for adult epilepsy patient
Brussels (Belgium), Atlanta (Georgia, USA), 19 January 2017 – 18:30 (CET): UCB has today announced the filing of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for BRIVIACT® (brivaracetam) CV as monotherapy in the treatment of partial-onset seizures in patients 16 years of age and older with epilepsy within the U.S.
DALLAS, TX — JANUARY 9, 2017 — Flow MedTech — Today Flow MedTech, Inc., an early-stage company developing an implantable medical device to prevent strokes in people with irregular heart rhythms, announces the appointment of Senthil Thambidorai, MD, FHRS, as Vice President of Medical Affairs.
Healthcare tech company Athenahealth (Nasdaq: ATHN) will add about 500 jobs in Atlanta.
A Smyrna-based developer of vaccines against Zika, Ebola, HIV and other infectious diseases has named a new chief scientific officer.
WASHINGTON--(BUSINESS WIRE)--The BioGENEius Challenges and Leadership Awards are organized by the Biotechnology Institute, a U.S. based organization dedicated to biotechnology education, and will be announced during the 2016 BIO International Convention, which is being held June 6-9 in San Francisco. Generous support from sponsors include Johnson & Johnson Innovation and the Biotechnology Innovation Organization.
|Neon CRM by Neon One|